Table 3. Gender subgroup of UGIB and subsequent risk of AMI in CAD patients.

UGIB, upper gastrointestinal bleeding; AMI, acute myocardial infarction; CAD, coronary artery disease; OR, odds ratio. Adjusted by antiplatelet use.

Male
Variable	Case (AMI[+])	Control (AMI[−])	Adjusted OR	P-value
UGIB
Yes, n (%)	125 (11.56)	563 (8.55)	1.65 (1.28–2.13)	0.0001
No, n (%)	956 (88.44)	6,023 (91.45)	1.00
Female
Variable	Case (AMI[+])	Control (AMI[−])	Adjusted OR	P-value
UGIB
Yes, n (%)	117 (19.63)	327 (9.41)	2.70 (2.03–3.57)	<0.0001
No, n (%)	479 (80.37)	3,149 (90.59)	1.00